Search
Healthy Clinical Trials in Lincoln, NE
A listing of 5 Healthy clinical trials in Lincoln, NE actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 5 of 5
The city of Lincoln, Nebraska, currently has 5 active clinical trials seeking participants for Healthy research studies.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Buy Retatrutide Online Through Celia
Recruiting
Retatrutide (formerly M25) is an investigational peptide being studied for its potential in supporting weight management and metabolic health. It acts on GLP-1, GIP, and glucagon receptors to influence appetite, energy regulation, and fat metabolism.
Conditions:
Healthy
Featured Offer
Find the Best GLP-1 Weight Loss Providers (2025)
Recruiting
Cutting-edge GLP-1 treatments like semaglutide and tirzepatide are helping thousands lose weight with medically guided support. But with so many online providers, how do you know which programs are trusted, affordable, and right for you?
We reviewed the top GLP-1 brands of 2025 — comparing pricing, prescription process, shipping, pharmacy partners, and real user ratings — to help you find a safe, convenient, and effective path toward your weight-loss goals.
- 100% online programs
- Licensed U.S. clinicians
- Fast shipping & flexible payments
See the rankings & choose the GLP-1 provider that fits your life.
We reviewed the top GLP-1 brands of 2025 — comparing pricing, prescription process, shipping, pharmacy partners, and real user ratings — to help you find a safe, convenient, and effective path toward your weight-loss goals.
- 100% online programs
- Licensed U.S. clinicians
- Fast shipping & flexible payments
See the rankings & choose the GLP-1 provider that fits your life.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
Featured Trial
Get Your Massachusetts Medicinal Marijuana Card (10% Off)
Recruiting
Elevate Holistics connects patients with licensed physicians who guide them through their state’s eligibility process for qualifying conditions such as chronic pain, anxiety disorders, or sleep challenges. Compassionate, compliant care every step of the way.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Conditions:
Pain
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Depression
Featured Trial
Get Your Lousiana Medicinal Marijuana Card (10% Off)
Recruiting
Elevate Holistics connects patients with licensed physicians who guide them through their state’s eligibility process for qualifying conditions such as chronic pain, anxiety disorders, or sleep challenges. Compassionate, compliant care every step of the way.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Use code PACSHORE10 for 10% off your consultation fee.
For adults 21+ or qualifying patients under state law. Availability varies by state.
Conditions:
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Depression
Major Depressive Disorder
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
Recruiting
This study will be conducted to assess the safety, tolerability, and pharmacokinetics of INCB000631 when administered orally to healthy adult participants.
Gender:
ALL
Ages:
Between 19 years and 55 years
Trial Updated:
08/15/2025
Locations: Celerion, Inc, Lincoln, Nebraska
Conditions: Healthy Participants
A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
Recruiting
This is a randomized, double-blind, placebo controlled First in human (FIH) trial of TBD11, administered to healthy adults. The trial will be conducted in two parts. Part 1 will consist of single ascending dose (SAD) and Food effect (FE) cohorts, and Part 2 will consist of multiple ascending dose (MAD) cohorts.
Gender:
ALL
Ages:
Between 19 years and 55 years
Trial Updated:
08/01/2025
Locations: Celerion, Lincoln, Nebraska
Conditions: Healthy Adult Participants
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Recruiting
Epstein Barr virus (EBV) is a virus which can cause infectious mononucleosis and is associated with certain kinds of cancer and multiple sclerosis. Researchers are looking for new ways to prevent disease related to EBV and have developed a new study vaccine (V350A and V350B). The main goal of this study is to learn about the safety and tolerability of V350A and V350B in healthy adults.
Gender:
ALL
Ages:
Between 18 years and 30 years
Trial Updated:
07/30/2025
Locations: Velocity Clinical Research Lincoln ( Site 0004), Lincoln, Nebraska
Conditions: Healthy
First-in-human Study of Orally Administered KT-621 in Healthy Adult Participants
Recruiting
This is a first-in-human study to evaluate safety, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-621 in healthy male and female adult participants.
Gender:
ALL
Ages:
Between 19 years and 55 years
Trial Updated:
03/21/2025
Locations: Celerion, Lincoln, Nebraska
Conditions: Healthy Participants Study
Relative Bioavailability of NX-5948 Tablets Vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets
Recruiting
This is a 2-cohort, fixed-sequence, 3-period, relative bioavailability, food-effect, and drug-drug interaction study. It is an open-label study evaluating the relative bioavailability of NX-5948 tablets compared to capsules, and the effect of food and an acid-reducing agent on the pharmacokinetics (PK) of NX-5948.
Gender:
ALL
Ages:
Between 19 years and 55 years
Trial Updated:
12/13/2024
Locations: Celerion, Lincoln, Nebraska
Conditions: Healthy Volunteer
